Please wait a minute...
Clinical and Experimental Obstetrics & Gynecology  2018, Vol. 45 Issue (3): 367-374    DOI: 10.12891/ceog4032.2018
Original Research Previous articles | Next articles
Association of plasma homocysteine, folic acid levels, and C677T polymorphism in methylene tetra hydrofolate reductase with risk of preeclampsia: a case-control study in Iranian women
A. Jafari1, S. Parchami2, S. Reiisi3, S. Miraj4, *()
1 Department of Obstetrics and Gynecology, Shahrekord University of Medical Sciences, Shahrekord, Iran
2 Cellular and Molecular Research Center, Shahrekord University of Medical Sciences, Shahrekord, Iran
3 Department of Genetics, Faculty of Basic Sciences, University of Shahrekord, Shahrekord, Iran
4 Department of of Obstetrics and Gynecology, Fellowship of Infertility, Faculty of Medicine, Shahrekord University of Medical Sciences, Shahrekord, Iran
Download:  PDF
Export:  BibTeX | EndNote (RIS)      
Abstract  
Introduction: Preeclampsia is the most dangerous hypertension with unknown etiology. Preeclampsia is a kind of pregnancy-specific syndrome. Objective: The aim of this study was to evaluate the correlation between C677T polymorphism of MTHFR gene, folic acid, and homocysteine serum levels in Iranian pregnant women with preeclampsia. Materials and Methods: This study was performed in 129 pre-eclamptic pregnant women and 125 control individuals and MTHFR gene (C677T polymorphism) was determined by PCRRFLP method, and the plasma levels of the homocysteine and acid folic was measured by ELISA method. Result: The CC, CT, and TT genotypes were not significantly different in patients compared to control (p = 0.614). Low mean levels of homocysteine and folic acid in the preeclamptic cases were observed compared to control group. The levels of BMI, gestational age, and neonatal weight were statistically different in two groups and other variables revealed no significant difference between these groups. Conclusion: These findings showed that there was no correlation between the C677T polymorphism of MTHFR gene and preeclampsia but the TT genotype of C677T polymorphism seems to be a protective factor for preeclampsia. It is also concluded that in this study, homocysteine and folic acid serum levels and BMI are significantly affected in patients with preeclampsia compared to controls and can increase the risk of developing sever side effect to mothers and neonates.
Key words:  Preeclampsia      Methylenetetrahydrofolate reductase (MTHFR)      C677T polymorphism      Folic acid      Homocysteine     
Published:  10 June 2018     
*Corresponding Author(s):  S. MIRAJ     E-mail:  miraj.sepideh@gmail.com

Cite this article: 

A. Jafari, S. Parchami, S. Reiisi, S. Miraj. Association of plasma homocysteine, folic acid levels, and C677T polymorphism in methylene tetra hydrofolate reductase with risk of preeclampsia: a case-control study in Iranian women. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(3): 367-374.

URL: 

https://ceog.imrpress.com/EN/10.12891/ceog4032.2018     OR     https://ceog.imrpress.com/EN/Y2018/V45/I3/367

[1] H.M. Kim, Y.S. Choo, W.J. Seong. Serum NT-proBNP levels as a marker for cardiopulmonary function in preeclampsia[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(4): 511-515.
[2] H. Yolli, M.E. Demir, R. Yildizhan. Neutrophil gelatinase associated lipocalin-2 (Ngal) levels in preeclampsia[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(4): 519-523.
[3] A.E. Kholeif, M.Y. Khamis, S. Eltabakh, R.S. Swilam, A. Elhabashy, R. EISherif. Prediction of severity of preeclampsia in Egyptian patients: role of neutrophil/lymphocyte ratio, platelet/lymphocyte ratio and C-reactive protein[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(2): 183-188.
[4] J. Yoon Park, S.W. Lee, K.J. Oh, J.-S. Hong. High mean blood pressure during the first trimester is predictive of future preeclampsia development in healthy pregnant women: a cohort study in Korea[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(5): 770-775.
[5] Y.E. Purut, E.E. Buyukbayrak, F. Ercan, A. Orcun, M. Menke, A.Y. Karageyim Karsidag. Do first trimester maternal serum follistatin like 3 levels predict preeclampsia and/or related adverse pregnancy outcomes?[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(2): 195-200.
[6] E. Ertekin, Ö. Tunçyürek, S. Kafkas, Y. Özsunar. Does the placental strain ratio correlate with the umbilical artery Doppler values?[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(2): 227-230.
[7] A. Simsek, S. Uludag, A. Tuten, A. S. Acikgoz, S. Uludag. Maternal and perinatal outcomes in early onset and late onset preeclampsia[J]. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(6): 837-841.
[8] B. Dullaert, S. Schroven, Y. Jacquemyn. The effect of maternal vitamin D status on pregnancy outcome and child health in the first year of life[J]. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(5): 677-681.
[9] G. Giunta, C. Cardea, M.G. Matarazzo, M.M. Panella, A.M.C. Rapisarda, S. Caruso, A. Cianci. Is calcium levofolinate pentahydrate more effective than folic acid in young healthy women before conception?[J]. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(5): 687-691.
[10] Jinqi Ma, Hua Yao. Persistent hypertension post-preeclampsia: a tertiary care centre-based study in China[J]. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(5): 741-744.
[11] R. Einikytė, A. Dapkeviciute, V. Dzenkeviciute, S. Kasnauskiene, V. Sapoka, D. Ramasauskaite. The importance of angiogenic and antiangiogenic biomarkers in pathogenesis and early diagnosis of preeclampsia[J]. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(4): 485-492.
[12] H. Kobayashi, T. Tsunemi, J. Akasaka, N. Koike, A. Shigemitsu. F. Ito, Y. Yamada, E. Fujii. Preeclampsia as a parental epigenetic disease[J]. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(4): 493-502.
[13] E. Shim, J.Y. Park, H.J. Seol. Placental expression of retinol-binding protein 4 in patients with preeclampsia[J]. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(1): 98-101.
[14] R. Lukic, M. Djukic, I. Soldatovic, N. Karadzov Orlic, D. Ardalic, G. Dragovic, Z. Mikovic. Prediction of preeclampsia using extreme first-trimester PAPP-A, free βhCG and uterine artery Doppler in resource limited settings[J]. Clinical and Experimental Obstetrics & Gynecology, 2017, 44(6): 851-855.
[15] T. Tsunemi, T. Sado, K. Naruse, H. Kobayashi. Paternal contribution to the preeclampsia phenotype[J]. Clinical and Experimental Obstetrics & Gynecology, 2017, 44(6): 914-922.
No Suggested Reading articles found!